Capecitabine with/without mitomycin C: Results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma

S. Cereda, M. Milella, S. Cordio, F. Leone, G. Aprile, A. Galiano, S. Mosconi, E. Vasile, D. Santini, Carmen Belli, A. Auriemma, A. Novarino, V. Vaccaro, C. Martines, D. Marino, S. E. Lutrino, V. Palazzo, B. Reinach, L. Aldrighetti, M. ReniLuigia Scudeller

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Capecitabine with/without mitomycin C: Results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds